You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARBs

Showing 1 - 25 of 298
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease Trial in Nablus (Continue ACEI or ARBs ( Enalapril

Recruiting
  • Contrast-induced Nephropathy
  • +2 more
  • Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan )
  • Hold ACEI or ARBs
  • Nablus, West Bank, Palestinian Territory, occupied
    An-Najah National University Hospital
Feb 27, 2022

Angiotensin Converting Enzyme Inhibitors and Angiotensin

Not yet recruiting
  • COVID-19 Pneumonia
  • Covid_19
  • (no location specified)
Jun 5, 2022

Compare Hospitalization Between Naive Sacubitril/Valsartan and

Completed
  • Heart Failure
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Pathophysiologic Hemodynamics After Primary Unilateral Total Hip

Recruiting
  • Orthostatic Intolerance
  • Orthostatic Hypotension
  • Mobilisation procedure
  • Copenhagen, Denmark
    Hvidovre University Hospital
Apr 8, 2021

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

Active, not recruiting
  • Chronic Kidney Disease
  • +3 more
  • Continuation of ACEi and/or ARBs
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2021

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection Trial in Paris (1: discontinuation of

Terminated
  • History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection
  • 1: discontinuation of RAS blocker therapy
  • 2: continuation of RAS blocker therapy
  • Paris, France
    Cardiologie, Groupe Hospitalier Pitié-Salpêtrière
Apr 8, 2021

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

Hypertension, Non-Dipping Trial in Hong Kong (ACEi, ARB)

Terminated
  • Hypertension
  • Non-Dipping
  • ACEi, ARB
  • Hong Kong, Hong Kong
    Lek Yuen Clinic
Apr 7, 2020

Host Response Mediators in Coronavirus (COVID-19) Infection

Unknown status
  • COVID-19
  • SARS-CoV2
  • ARBs and/or ACE inhibitors
  • Usual Care
  • Calgary, Alberta, Canada
  • +14 more
Aug 11, 2020

Coronavirus Disease 2019 Patients Receiving Receiving

Completed
  • COVID-19
  • Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Aug 1, 2020

The Effect of RAAS Blockers on ACE2 Levels

Completed
  • Renin-Angiotensin System
  • ACE inhibitor ,angiotensin receptor blockers
  • Cairo, Select A State Or Province, Egypt
    Ainshams University
Jun 10, 2022

ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

Recruiting
  • Heart Failure
  • Mortality
  • Angiotensin receptor neprilysin inhibitor (ARNI)
  • Renin-Angiotensin System Inhibitor (RAS inhibitor)
  • Wonju, Gangwondo, Korea, Republic of
    Yonsei University Wonju College of Medicine
Dec 20, 2022

Primary IgA Nephrology Trial in Beijing (Nefecon)

Not yet recruiting
  • Primary IgA Nephrology
  • Beijing, Beijing, China
    Peking University First Hospital
Sep 6, 2022

Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)

Completed
  • Coronavirus Disease 2019
  • COVID-19
  • Angiotensin Receptor Blockers
  • Placebo
  • Camperdown, New South Wales, Australia
  • +21 more
Mar 2, 2022

Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

Not yet recruiting
  • Diabetic Nephropathy Type 2
  • Empagliflozin 25 MG
  • Enalapril Maleate 20 mg
  • (no location specified)
May 9, 2022

Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)

Not yet recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Diabete Type 2
  • Cairo, Egypt
    clinical research uint- El-sheikh zayed specialized hospital SMC
Oct 8, 2023

Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)

Recruiting
  • Angiotensin/Renin/Aldosterone Hypertension
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Aug 16, 2022

Primary IgA Nephropathy Trial in Uppsala (Nefecon)

Recruiting
  • Primary IgA Nephropathy
  • Uppsala, Sweden
    Uppsala University Hospital
Jul 27, 2021

Acute Decompensated Heart Failure Trial in Gainesville (Change of treatment plan)

Completed
  • Acute Decompensated Heart Failure
  • Change of treatment plan
  • Gainesville, Florida
    UF Health at the University of Florida
Apr 21, 2021

Heart Failure, Cardiomyopathy, Dilated, Cardiomyopathies Trial (Other)

Not yet recruiting
  • Heart Failure
  • +3 more
  • (no location specified)
Oct 17, 2023

Participants Hospitalized With Coronavirus Disease 2019 in Japan

Completed
  • COVID-19
    • Minato-ku, Tokyo, Japan
    • +1 more
    May 9, 2022

    Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

    Completed
    Has Results
    • Hypertension
    • COVID-19
    • Angiotensin converting enzyme inhibitor
    • +2 more
    • Kiev, Please Select, Ukraine
      Medical Practice Prof D.Ivanov
    Feb 16, 2022

    Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

    Recruiting
    • Lupus Nephritis
    • ANX009
    • Angeles City, Philippines
    • +6 more
    Mar 10, 2023